Eurofins Scientific SE
ERF
Classement en actions
#1410
Eurofins Scientific SE, together with its subsidiaries, provides various... Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.
Prix de l'action
$90.13
Capitalisation boursière
$15.65B
Changement (1 jour)
-3.81%
Changement (1 an)
24.32%
Pays
LU
Échange Eurofins Scientific SE (ERF)
Catégorie
Healthcare
Revenus pour Eurofins Scientific SE (ERF)
Revenus en Jun 2026 TTM : $8.76B
Selon les derniers rapports financiers de Eurofins Scientific SE, le chiffre d'affaires actuel de l'entreprise (TTM) est de $8.76B. En 2024, l'entreprise a réalisé un chiffre d'affaires de $7.23B une augmentation par rapport à le chiffre d'affaires de l'année 2023, qui était de $7.20B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Eurofins Scientific SE de 2002 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $8.76B | 2.33% |
| 2025 | $8.56B | 18.35% |
| 2024 | $7.23B | 0.43% |
| 2023 | $7.20B | 0.02% |
| 2022 | $7.20B | -5.75% |
| 2021 | $7.64B | 15.33% |
| 2020 | $6.62B | 29.39% |
| 2019 | $5.12B | 17.82% |
| 2018 | $4.35B | 21.87% |
| 2017 | $3.57B | 33.59% |
| 2016 | $2.67B | 26.05% |
| 2015 | $2.12B | 24.10% |
| 2014 | $1.71B | 1.24% |
| 2013 | $1.69B | 22.39% |
| 2012 | $1.38B | 28.33% |
| 2011 | $1.07B | 17.97% |
| 2010 | $909.59M | -0.89% |
| 2009 | $917.78M | 4.08% |
| 2008 | $881.83M | 22.68% |
| 2007 | $718.83M | 48.46% |
| 2006 | $484.20M | 75.80% |
| 2005 | $275.43M | 15.73% |
| 2004 | $238.00M | 12.05% |
| 2003 | $212.41M | 25.25% |
| 2002 | $169.59M | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| $46.34B | 428.96% |
US
|
|
| $25.11B | 186.62% |
US
|
|
| $2.71B | -69.10% |
US
|
|
| - | - |
CN
|
|
| $7.37B | -15.84% |
US
|
